Valeant to Name New CEO as Pearson Hospitalized, WSJ SaysBy
Schiller, Rosiello may be candidates, newspaper says
Pearson remains on medical leave for severe pneumonia
Valeant Pharmaceuticals International Inc. will name a new chief executive officer to lead the company while Michael Pearson remains hospitalized after contracting severe pneumonia, the Wall Street Journal reported Tuesday.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.